ZA917148B - Mometasone furoate monohydrate,process for making same and pharmaceutical compositions - Google Patents

Mometasone furoate monohydrate,process for making same and pharmaceutical compositions

Info

Publication number
ZA917148B
ZA917148B ZA917148A ZA917148A ZA917148B ZA 917148 B ZA917148 B ZA 917148B ZA 917148 A ZA917148 A ZA 917148A ZA 917148 A ZA917148 A ZA 917148A ZA 917148 B ZA917148 B ZA 917148B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
mometasone furoate
making same
furoate monohydrate
monohydrate
Prior art date
Application number
ZA917148A
Other languages
English (en)
Inventor
Pui-Ho Yuen
Yuen Pui-Ho
Charles Eckhart
Eckhart Charles
Teresa Etlinger
Etlinger Teresa
Nancy Levine
Levine Nancy
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA917148(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA917148B publication Critical patent/ZA917148B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA917148A 1990-09-10 1991-09-09 Mometasone furoate monohydrate,process for making same and pharmaceutical compositions ZA917148B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10

Publications (1)

Publication Number Publication Date
ZA917148B true ZA917148B (en) 1992-08-26

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917148A ZA917148B (en) 1990-09-10 1991-09-09 Mometasone furoate monohydrate,process for making same and pharmaceutical compositions

Country Status (35)

Country Link
US (1) US6180781B1 (OSRAM)
EP (1) EP0548114B1 (OSRAM)
JP (1) JPH0725789B2 (OSRAM)
KR (1) KR960013445B1 (OSRAM)
CN (1) CN1030920C (OSRAM)
AT (1) ATE113604T1 (OSRAM)
AU (1) AU663471B2 (OSRAM)
BG (1) BG60755B2 (OSRAM)
CA (1) CA2091360C (OSRAM)
CZ (1) CZ281318B6 (OSRAM)
DE (2) DE69104991T2 (OSRAM)
DK (1) DK0548114T5 (OSRAM)
EE (1) EE02962B1 (OSRAM)
ES (1) ES2065701T3 (OSRAM)
FI (1) FI111078B (OSRAM)
HK (1) HK185996A (OSRAM)
HR (1) HRP920383B1 (OSRAM)
HU (1) HU213401B (OSRAM)
IE (1) IE67056B1 (OSRAM)
IL (1) IL99437A (OSRAM)
LU (1) LU90366I2 (OSRAM)
MX (2) MX9203396A (OSRAM)
MY (1) MY106644A (OSRAM)
NL (1) NL980012I2 (OSRAM)
NO (1) NO300548B1 (OSRAM)
NZ (1) NZ239711A (OSRAM)
OA (1) OA09772A (OSRAM)
PH (1) PH30443A (OSRAM)
PL (1) PL165803B1 (OSRAM)
PT (1) PT98905B (OSRAM)
SI (1) SI9111497A (OSRAM)
TW (2) TW229208B (OSRAM)
WO (1) WO1992004365A1 (OSRAM)
YU (1) YU48666B (OSRAM)
ZA (1) ZA917148B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065701T3 (es) * 1990-09-10 1995-02-16 Schering Corp Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
JP3676674B2 (ja) * 1997-10-09 2005-07-27 シェーリング コーポレイション 噴霧のためのモメタゾンフロエート懸濁液
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
PT1175433E (pt) 1999-05-04 2005-11-30 Strakan Int Ltd Glicosidos androgenos e sua actividade androgenica
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
BRPI0717058A2 (pt) * 2006-09-22 2013-10-15 Ranbaxy Lab Ltd Composto, composição farmacêutica, método para tratar, prevenir, inibir ou suprimir uma condição inflamatória ou doença ou doenças do sistema nervoso central e método para a preparação de um composto
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
ATE545417T1 (de) 2007-03-14 2012-03-15 Ranbaxy Lab Ltd Pyrazoloä3,4-büpyridin-derivate als phosphodiesterasehemmer
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
EP3106149B1 (en) 2009-05-29 2019-11-20 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta-2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
BR112015022784B1 (pt) 2013-03-15 2023-02-14 Pearl Therapeutics, Inc Método de condicionamento de material cristalino micronizado e sistemas de condicionamento
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057401B1 (en) * 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
ES2065701T3 (es) * 1990-09-10 1995-02-16 Schering Corp Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.

Also Published As

Publication number Publication date
PT98905B (pt) 1998-08-31
HUT64361A (en) 1993-12-28
NL980012I1 (nl) 1998-05-06
ATE113604T1 (de) 1994-11-15
NL980012I2 (nl) 2004-11-01
MX9203396A (es) 1992-07-31
HU9300685D0 (en) 1993-06-28
CZ281318B6 (cs) 1996-08-14
NO300548B1 (no) 1997-06-16
JPH05506667A (ja) 1993-09-30
YU48666B (sh) 1999-06-15
CN1030920C (zh) 1996-02-07
FI111078B (fi) 2003-05-30
WO1992004365A1 (en) 1992-03-19
EE02962B1 (et) 1997-02-17
MX9100990A (es) 1992-05-04
US6180781B1 (en) 2001-01-30
KR960013445B1 (ko) 1996-10-05
NO930693L (no) 1993-02-26
SI9111497A (sl) 1998-04-30
CZ38393A3 (en) 1994-01-19
HK185996A (en) 1996-10-11
LU90366I2 (fr) 1999-05-05
BG60755B2 (bg) 1996-02-29
TW229208B (OSRAM) 1994-09-01
PH30443A (en) 1997-05-09
YU149791A (sh) 1994-01-20
DK0548114T5 (da) 1995-01-30
MY106644A (en) 1995-07-31
HRP920383B1 (en) 2000-04-30
PT98905A (pt) 1992-09-30
EP0548114B1 (en) 1994-11-02
CN1059911A (zh) 1992-04-01
DE69104991D1 (de) 1994-12-08
CA2091360C (en) 1997-04-08
OA09772A (en) 1993-11-30
IE913155A1 (en) 1992-03-11
DE19875032I2 (de) 2007-04-19
ES2065701T3 (es) 1995-02-16
NZ239711A (en) 1992-09-25
HRP920383A2 (en) 1998-06-30
PL165803B1 (pl) 1995-02-28
NO930693D0 (no) 1993-02-26
IL99437A0 (en) 1992-08-18
IE67056B1 (en) 1996-02-21
HU213401B (en) 1997-06-30
TW272195B (OSRAM) 1996-03-11
DE69104991T2 (de) 1995-04-20
AU8497491A (en) 1992-03-30
AU663471B2 (en) 1995-10-12
JPH0725789B2 (ja) 1995-03-22
FI931031L (fi) 1993-03-09
FI931031A0 (fi) 1993-03-09
CA2091360A1 (en) 1992-03-11
IL99437A (en) 1995-05-29
EP0548114A1 (en) 1993-06-30

Similar Documents

Publication Publication Date Title
TW229208B (OSRAM)
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
CA2152771A1 (en) 7-o-ethers of taxane derivatives
DE3063905D1 (en) Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
ES8604731A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
ES8800198A1 (es) Procedimiento para preparar derivados de acidos aziridin-2- carboxilicos substituidos en n
IL66192A (en) Albomycin derivatives,their production and pharmaceutical compositions containing them
IL96814A0 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom,processes for the preparation thereof and pharmaceutical compositions containing them
ZA912180B (en) Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
JO1711B1 (en) Therapeutic agents
IT1269740B (it) Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione
GB9018263D0 (en) Tricyclo compounds,processes for their production and pharmaceutical compositions containing the same